Eviplera Articles
Germany's G-BA backs Eisai's Halaven; IQWiG finds some added benefit for Eliquis and rilpivirine
23 April 2012
Gilead and Johnson & Johnson get EU backing for HIV drugs Eviplera and Edurant, respectively
29 November 2011
More news from EMA/CHMP September meeting
26 September 2011
Showing 1-4 of 4 articles
- 1
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
